A case of reactivation of varicella–zoster virus after BNT162b2 vaccine second dose?

We report a case of itchy papulovesicular rash consistent with varicella–zoster virus reactivation after Pfizer-BioNTech vaccine second dose administration. While there have been cases of varicella–zoster virus reactivation due to COVID-19 or COVID-19 vaccine inoculation in older individuals with pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Santovito, Luca Spiro, Pinna, Graziano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364300/
https://www.ncbi.nlm.nih.gov/pubmed/34390376
http://dx.doi.org/10.1007/s00011-021-01491-w
_version_ 1783738504612675584
author Santovito, Luca Spiro
Pinna, Graziano
author_facet Santovito, Luca Spiro
Pinna, Graziano
author_sort Santovito, Luca Spiro
collection PubMed
description We report a case of itchy papulovesicular rash consistent with varicella–zoster virus reactivation after Pfizer-BioNTech vaccine second dose administration. While there have been cases of varicella–zoster virus reactivation due to COVID-19 or COVID-19 vaccine inoculation in older individuals with pre-existing conditions, this case report describes the first case of varicella–zoster virus reactivation on a healthy, young male in the absence of pre-existing conditions. The mechanisms underlying varicella-zoster virus reactivation in patients with COVID-19 are unknown and should be further characterized.
format Online
Article
Text
id pubmed-8364300
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-83643002021-08-15 A case of reactivation of varicella–zoster virus after BNT162b2 vaccine second dose? Santovito, Luca Spiro Pinna, Graziano Inflamm Res Short Communication We report a case of itchy papulovesicular rash consistent with varicella–zoster virus reactivation after Pfizer-BioNTech vaccine second dose administration. While there have been cases of varicella–zoster virus reactivation due to COVID-19 or COVID-19 vaccine inoculation in older individuals with pre-existing conditions, this case report describes the first case of varicella–zoster virus reactivation on a healthy, young male in the absence of pre-existing conditions. The mechanisms underlying varicella-zoster virus reactivation in patients with COVID-19 are unknown and should be further characterized. Springer International Publishing 2021-08-14 2021 /pmc/articles/PMC8364300/ /pubmed/34390376 http://dx.doi.org/10.1007/s00011-021-01491-w Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Short Communication
Santovito, Luca Spiro
Pinna, Graziano
A case of reactivation of varicella–zoster virus after BNT162b2 vaccine second dose?
title A case of reactivation of varicella–zoster virus after BNT162b2 vaccine second dose?
title_full A case of reactivation of varicella–zoster virus after BNT162b2 vaccine second dose?
title_fullStr A case of reactivation of varicella–zoster virus after BNT162b2 vaccine second dose?
title_full_unstemmed A case of reactivation of varicella–zoster virus after BNT162b2 vaccine second dose?
title_short A case of reactivation of varicella–zoster virus after BNT162b2 vaccine second dose?
title_sort case of reactivation of varicella–zoster virus after bnt162b2 vaccine second dose?
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364300/
https://www.ncbi.nlm.nih.gov/pubmed/34390376
http://dx.doi.org/10.1007/s00011-021-01491-w
work_keys_str_mv AT santovitolucaspiro acaseofreactivationofvaricellazostervirusafterbnt162b2vaccineseconddose
AT pinnagraziano acaseofreactivationofvaricellazostervirusafterbnt162b2vaccineseconddose
AT santovitolucaspiro caseofreactivationofvaricellazostervirusafterbnt162b2vaccineseconddose
AT pinnagraziano caseofreactivationofvaricellazostervirusafterbnt162b2vaccineseconddose

Ejemplares similares